FABP4 and autism spectrum disorder: found that FABP4 knockout mice had changes in fatty acid composition in the cortex, and suggested that an ‘adipo-brain axis’ may underlie the pathophysiology of autism spectrum disorder, and that FABP4 could potentially be used as a biomarker (36).